06 July 2018

Recently, the Polish Authorities (MPI, Main Pharmaceutical Inspectorate) conducted two inspections at Polpharma API Plant.

Both inspections finished with a positive result, the inspectors will recommend the issue of GMP certificates for all the substances evaluated. This was a further acknowledgment that the API Plant meets GMP requirements, and the certificate makes it possib le to sell our products around the world.

This is the best confirmation that We deliver quality.


In September, our recently developed active substances were accepted by MPI:

  • Bazedoxifene Acetate
  • Brexpiprazole
  • Aripiprazole Monohydrate

as well as:

  • Piracetam
  • Carvedilol
  • Tolterodine tartrate
  • Carbamazepine
  • Pentoxifylline

Moreover, in October MPI approved another 8 active substances from our portfolio:

  • Hydrochlorothiazide
  • Avanafil
  • Alendronate sodium trihydrate
  • Eodolac
  • Ticagrelor
  • Saxagliptin monohydrate
  • Zolendronic acid monohydrate
  • Metronizadole


Talk with our Salse Team!

Read more